Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 30, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,241,907

« Back to Dashboard

Which drugs does patent 7,241,907 protect, and when does it expire?

Patent 7,241,907 protects JEVTANA KIT and is included in one NDA. There are two tentative approvals for the compound protected by this patent. Additional details are available via the generic ingredient links below.

This patent has thirty-seven patent family members in thirty-two countries.

Summary for Patent: 7,241,907

Title:Acetone solvate of dimethoxy docetaxel and its process of preparation
Abstract:This invention discloses and claims an acetone solvate of dimethoxydocetaxel or 4-acetoxy-2.alpha.-benzoyloxy-5.beta.,20-epoxy-1-hydroxy-7.beta.,10.beta.- -dimethoxy-9-oxotax-11-en-13.alpha.-yl (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate and its preparation by crystallization from an aqueous/acetone solution.
Inventor(s): Didier; Eric (Paris, FR), Perrin; Marc-Antoine (Jouy en Josas, FR)
Assignee: Aventis Pharma S.A. (Antony, FR)
Application Number:10/944,254
Patent Claim Types:
see list of patent claims
Compound; Use; Process;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Sanofi Aventis Us
SOLUTION;IV (INFUSION)201023-001Jun 17, 2010RXYesYes7,241,907► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 7,241,907

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France03 11016Sep 19, 2003

International Patent Family for Patent: 7,241,907

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
France2859996► Subscribe
Spain2403149► Subscribe
European Patent Office1667986► SubscribeC01667986/01Switzerland► Subscribe
European Patent Office1667986► Subscribe92172Luxembourg► Subscribe
European Patent Office1667986► SubscribeCA 2013 00025Denmark► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus